SOPHIA GENETICS SA

Insider buys signal confidence in Sophia Genetics’ AI‑healthcare platform—CFO’s 112k-share purchase shows long‑term optimism amid steady growth.

Insider buying fuels optimism for Sophia Genetics: executives pile up shares, signalling confidence in its cloud‑genomics platform and future upside.

Insider sales at Sophia Genetics show routine RSU liquidation, not a decline in confidence; executives use Rule 10b5‑1 plans while the company’s cloud‑diagnostics growth remains strong.